Results 191 to 200 of about 20,710 (242)

Discontinuation of Heart Failure Pharmacotherapy in Older Adults With Frailty. [PDF]

open access: yesJ Am Heart Assoc
Nakamaru R   +5 more
europepmc   +1 more source

Soluble Neprilysin and Corin Concentrations in Relation to Clinical Outcome in Chronic Heart Failure

open access: yesJACC: Heart Failure, 2021
OBJECTIVES: This study investigated whether patients with chronic heart failure (HF) can be stratified according to the combination of soluble neprilysin and corin concentrations and whether this is related to clinical outcome.
Priya Vart, Elena Revuelta, Mar Domingo
exaly   +2 more sources

Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

open access: yesDiabetologia, 2019
peer reviewedNeprilysin is a widely expressed peptidase with broad substrate specificity that preferentially hydrolyses oligopeptide substrates, many of which regulate the cardiovascular, nervous and immune systems.
Nathalie Esser, Sakeneh Zraika
exaly   +2 more sources

Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances

open access: yesEuropean Journal of Heart Failure, 2015
This review describes the role of neprilysin (also known as neutral endopeptidase or enkephalinase) in the degradation of natriuretic and other vasoactive peptides, including bradykinin and adrenomedullin. The initial development of neprilysin inhibitors,
John McMurray
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Copper Downregulates Neprilysin Activity Through Modulation of Neprilysin Degradation

Journal of Alzheimer's Disease, 2010
Copper plays a central role in conserved processes such as respiration, and in highly specialized processes, such as protein modification. The metalloprotease neprilysin (NEP) degrades a variety of bioactive peptides and is involved in many physiological processes. However, very little is known about the regulation of NEP activity. In the current study,
Li Mi   +6 more
openaire   +2 more sources

Neuroendocrine Differentiation, Neuropeptides, and Neprilysin

American Journal of Respiratory Cell and Molecular Biology, 1999
Pulmonary neuroendocrine cells exhibit highly specialized differentiation with a neurosecretory phenotype and significant bioactive peptide hormone content. In addition to these functions, pulmonary neuroendocrine cells have been demonstrated to act as chemoreceptors for hypoxia (1).
A J, Cohen, Y E, Miller
openaire   +2 more sources

Tat peptides inhibit neprilysin

Journal of Neurovirology, 2006
Dementia associated with human immunodeficiency virus (HIV) infection occurs commonly in the aging population and amyloid depositions are noted in the brains of patients with HIV infection in younger age groups. This suggests a dysregulation of amyloid processing in the setting of HIV infection.
Abigail, Daily   +2 more
openaire   +2 more sources

Neprilysin Inhibitors in Cardiovascular Disease

Current Cardiology Reports, 2017
Mortality from heart failure remains high despite advances in medical therapy over the last three decades. Angiotensin receptor-neprilysin inhibitor (ARNI) combinations are the latest addition to the heart failure medical armamentarium, which is built on the cornerstone regimen of beta blockers, angiotensin converting enzyme (ACE) inhibitors ...
Guson, Kang, Dipanjan, Banerjee
openaire   +2 more sources

Home - About - Disclaimer - Privacy